Previous 10 | Next 10 |
home / stock / orxoy / orxoy news
Orexo announces last patient enrolled in pivotal study evaluating the efficacy of MODIA® in combination with sublingual buprenorphine/ naloxone for the treatment of OUD PR Newswire Study evaluating efficacy of MODIA®, a digital therapeutic, in addition to cli...
Orexo appoints Edward Kim, M.D., as new Chief Medical Officer PR Newswire UPPSALA, Sweden , Oct. 26, 2022 /PRNewswire/ -- Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), today welcomes Edward (Ed) Kim , M.D., as new Chief Medical Officer (CM...
Orexo´s Nomination Committee for the Annual General Meeting 2023 PR Newswire UPPSALA, Sweden , Oct. 17, 2022 /PRNewswire/ -- Prior to the Annual General Meeting (AGM) that will take place on April 18, 2023 , a Nomination Committee has been appoin...
Orexo announces positive data from phase 1 clinical study for OX640 - a nasal epinephrine rescue medication for allergic reactions PR Newswire All four investigational formulations of OX640 were extensively absorbed and rapidly achieved clinically relevant plasma lev...
Orexo's partner Trinity Health today announces the availability of vorvida® and deprexis® to patients PR Newswire UPPSALA, Sweden , Sept. 7, 2022 /PRNewswire/ -- Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY) today announces the Integrated Hea...
First patent issued in Europe for Orexo's adrenaline product OX640 PR Newswire UPPSALA, Sweden , Sept. 1, 2022 /PRNewswire/ -- Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY) today announces that the European Patent Office (EPO) has granted the first Eur...
Orexo to participate in Pareto Securities´ 13th Annual Healthcare Conference PR Newswire STOCKHOLM , Aug. 31, 2022 /PRNewswire/ -- Orexo AB (Publ.), (STO:ORX) (OTCQX:ORXOY), which develops improved pharmaceuticals and evidence-based digital ther...
Orexo AB press release ( OTCQX:ORXOY ): Q2 GAAP EPS of -SEK 1.04. Revenue of SEK 147.8M (+3.5% Y/Y). For further details see: Orexo AB GAAP EPS of -SEK 1.04, revenue of SEK 147.8M
Orexo Interim Report Q2 2022 PR Newswire UPPSALA, Sweden , July 14, 2022 /PRNewswire/ -- Good tailwind in the financial development Q2 2022 highlights Total net revenues of SEK 147.8 m (142.8) EBITDA of SEK -32.5 m...
Orexo's digital therapy deprexis® reimbursed under the US Veterans Affairs Federal Supply Schedule PR Newswire Orexo is granted a Veterans Affairs Federal Supply Schedule contract for deprexis® in the US and will be reimbursed and made available by the federa...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, June 21, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Science Virtual Investor Forum held June 20 th are now available for online viewing. REGISTER NOW AT : ...
NEW YORK, June 18, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda for the Life Sciences Virtual Investor Forum to be held on June 20 th , 2024. This event is co-sponsored by Zack’s Small Cap Research. ...
Orexo publishes prospectus and applies for admission to trading of social bonds on Nasdaq Stockholm PR Newswire UPPSALA, Sweden , May 10, 2024 /PRNewswire/ -- On March 28, 2024 , Orexo AB (publ), ("Orexo" or the " Company ") (STO: ORX) (OTCQX: ORXOY) succ...